trial · primary record
Toripalimab
Esophageal Squamous Cell Carcinoma (ESCC)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 340 |
| Primary completion | 2029-12-15 |
| Primary endpoint | 1 year Progress Free Survival (PFS) rate |
| Registry ID | NCT07246330 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:28.936Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07246330
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.